Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity.

CONCLUSIONS: Major racial underrepresentation exists in gynecologic oncology phase 1 clinical trials. Enrollment of more black participants is needed to achieve racial equity.
PMID: 32173047 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - March 12, 2020 Category: Cancer & Oncology Authors: Awad E, Paladugu R, Jones N, Pierce JY, Scalici J, Hamilton CA, Darcy KM, Maxwell GL, Rocconi RP Tags: Gynecol Oncol Source Type: research